Consolidated total income of the company stood at Rs 827.9 crore
Natco Pharma reported a 73.23 per cent increase in its consolidated net profit to Rs 203.9 crore for the quarter ended September mainly on account of robust sales.
The company had posted a net profit of Rs 117.7 crore for the corresponding period of the previous fiscal, Natco Pharma said.
Consolidated total income of the company stood at Rs 827.9 crore for the quarter under consideration. It was Rs 518.9 crore for the same period a year ago, it added.
The board of directors has recommended a second interim dividend of Rs 3 per equity share of Rs 2 each for the financial year 2020-21, the filing said.